196 related articles for article (PubMed ID: 20826588)
1. Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.
Haase CL; Tybjærg-Hansen A; Grande P; Frikke-Schmidt R
J Clin Endocrinol Metab; 2010 Dec; 95(12):E500-10. PubMed ID: 20826588
[TBL] [Abstract][Full Text] [Related]
2. Combined analysis of six lipoprotein lipase genetic variants on triglycerides, high-density lipoprotein, and ischemic heart disease: cross-sectional, prospective, and case-control studies from the Copenhagen City Heart Study.
Wittrup HH; Andersen RV; Tybjaerg-Hansen A; Jensen GB; Nordestgaard BG
J Clin Endocrinol Metab; 2006 Apr; 91(4):1438-45. PubMed ID: 16418216
[TBL] [Abstract][Full Text] [Related]
3. Hepatic lipase mutations,elevated high-density lipoprotein cholesterol, and increased risk of ischemic heart disease: the Copenhagen City Heart Study.
Andersen RV; Wittrup HH; Tybjaerg-Hansen A; Steffensen R; Schnohr P; Nordestgaard BG
J Am Coll Cardiol; 2003 Jun; 41(11):1972-82. PubMed ID: 12798568
[TBL] [Abstract][Full Text] [Related]
4. LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals.
Haase CL; Tybjærg-Hansen A; Qayyum AA; Schou J; Nordestgaard BG; Frikke-Schmidt R
J Clin Endocrinol Metab; 2012 Feb; 97(2):E248-56. PubMed ID: 22090275
[TBL] [Abstract][Full Text] [Related]
5. Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach.
Haase CL; Frikke-Schmidt R; Nordestgaard BG; Tybjærg-Hansen A
PLoS Genet; 2012; 8(11):e1003063. PubMed ID: 23209431
[TBL] [Abstract][Full Text] [Related]
6. Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.
Johannsen TH; Kamstrup PR; Andersen RV; Jensen GB; Sillesen H; Tybjaerg-Hansen A; Nordestgaard BG
J Clin Endocrinol Metab; 2009 Apr; 94(4):1264-73. PubMed ID: 19088157
[TBL] [Abstract][Full Text] [Related]
7. TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population.
Varbo A; Benn M; Tybjærg-Hansen A; Grande P; Nordestgaard BG
Arterioscler Thromb Vasc Biol; 2011 Feb; 31(2):451-7. PubMed ID: 21071687
[TBL] [Abstract][Full Text] [Related]
8. PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses.
Benn M; Nordestgaard BG; Grande P; Schnohr P; Tybjaerg-Hansen A
J Am Coll Cardiol; 2010 Jun; 55(25):2833-42. PubMed ID: 20579540
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation in ABCG1 and risk of myocardial infarction and ischemic heart disease.
Schou J; Frikke-Schmidt R; Kardassis D; Thymiakou E; Nordestgaard BG; Jensen G; Grande P; Tybjærg-Hansen A
Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):506-15. PubMed ID: 22155456
[TBL] [Abstract][Full Text] [Related]
10. Pentanucleotide repeat polymorphism, lipoprotein(a) levels, and risk of ischemic heart disease.
Kamstrup PR; Tybjaerg-Hansen A; Steffensen R; Nordestgaard BG
J Clin Endocrinol Metab; 2008 Oct; 93(10):3769-76. PubMed ID: 18682504
[TBL] [Abstract][Full Text] [Related]
11. Elevated remnant cholesterol causes both low-grade inflammation and ischemic heart disease, whereas elevated low-density lipoprotein cholesterol causes ischemic heart disease without inflammation.
Varbo A; Benn M; Tybjærg-Hansen A; Nordestgaard BG
Circulation; 2013 Sep; 128(12):1298-309. PubMed ID: 23926208
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein A1 genotype affects the change in high density lipoprotein cholesterol subfractions with exercise training.
Ruaño G; Seip RL; Windemuth A; Zöllner S; Tsongalis GJ; Ordovas J; Otvos J; Bilbie C; Miles M; Zoeller R; Visich P; Gordon P; Angelopoulos TJ; Pescatello L; Moyna N; Thompson PD
Atherosclerosis; 2006 Mar; 185(1):65-9. PubMed ID: 16005460
[TBL] [Abstract][Full Text] [Related]
13. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.
Frikke-Schmidt R; Nordestgaard BG; Stene MC; Sethi AA; Remaley AT; Schnohr P; Grande P; Tybjaerg-Hansen A
JAMA; 2008 Jun; 299(21):2524-32. PubMed ID: 18523221
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in APOB associated with increased low-density lipoprotein levels in both genders in the general population.
Benn M; Nordestgaard BG; Jensen JS; Grande P; Sillesen H; Tybjaerg-Hansen A
J Clin Endocrinol Metab; 2005 Oct; 90(10):5797-803. PubMed ID: 16030169
[TBL] [Abstract][Full Text] [Related]
15. Milk intake is not associated with ischaemic heart disease in observational or Mendelian randomization analyses in 98,529 Danish adults.
Bergholdt HK; Nordestgaard BG; Varbo A; Ellervik C
Int J Epidemiol; 2015 Apr; 44(2):587-603. PubMed ID: 26085675
[TBL] [Abstract][Full Text] [Related]
16. Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels.
Haase CL; Frikke-Schmidt R; Nordestgaard BG; Kateifides AK; Kardassis D; Nielsen LB; Andersen CB; Køber L; Johnsen AH; Grande P; Zannis VI; Tybjaerg-Hansen A
J Intern Med; 2011 Aug; 270(2):136-46. PubMed ID: 21443680
[TBL] [Abstract][Full Text] [Related]
17. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction.
Jørgensen AB; Frikke-Schmidt R; West AS; Grande P; Nordestgaard BG; Tybjærg-Hansen A
Eur Heart J; 2013 Jun; 34(24):1826-33. PubMed ID: 23248205
[TBL] [Abstract][Full Text] [Related]
18. Context-dependent associations between variation in risk of ischemic heart disease and variation in the 5' promoter region of the apolipoprotein E gene in Danish women.
Stengård JH; Dyson G; Frikke-Schmidt R; Tybjaerg-Hansen A; Nordestgaard BG; Sing CF
Circ Cardiovasc Genet; 2010 Feb; 3(1):22-30. PubMed ID: 20160192
[TBL] [Abstract][Full Text] [Related]
19. Common and rare alleles in apolipoprotein B contribute to plasma levels of low-density lipoprotein cholesterol in the general population.
Benn M; Stene MC; Nordestgaard BG; Jensen GB; Steffensen R; Tybjaerg-Hansen A
J Clin Endocrinol Metab; 2008 Mar; 93(3):1038-45. PubMed ID: 18160469
[TBL] [Abstract][Full Text] [Related]
20. Gene polymorphisms affecting HDL-cholesterol levels in the normolipidemic population.
Miltiadous G; Hatzivassiliou M; Liberopoulos E; Bairaktari E; Tselepis A; Cariolou M; Elisaf M
Nutr Metab Cardiovasc Dis; 2005 Jun; 15(3):219-24. PubMed ID: 15955471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
